Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Acorda Therapeutics (ACORQ)
OTHER OTC:ACORQ
RESEARCH TOOLSreports
Acorda Therapeutics (ACORQ) Financial Statements
600 Followers
Acorda Therapeutics Financial Overview
| Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | $ 20.29M | $ 37.98M | $ 27.71M | $ 29.68M | $ 22.26M |
| Gross Profit | $ 16.58M | $ 32.39M | $ 24.33M | $ 26.61M | $ 19.02M |
| EBIT | $ -18.84M | $ -247.66M | $ -1.96M | $ -3.57M | $ -11.29M |
| EBITDA | $ -12.63M | $ -234.64M | $ 10.84M | $ 9.01M | $ 1.09M |
| Net Income Common Stockholders | $ -27.39M | $ -217.76M | $ -8.89M | $ -9.38M | $ -16.82M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 9.36M | $ 29.98M | $ 32.47M | $ 26.10M | $ 37.24M |
| Total Assets | $ 81.58M | $ 108.53M | $ 366.34M | $ 364.70M | $ 372.52M |
| Total Debt | $ 195.92M | $ 190.90M | $ 186.09M | $ 181.50M | $ 177.11M |
| Net Debt | $ 186.56M | $ 160.92M | $ 153.62M | $ 155.40M | $ 139.86M |
| Total Liabilities | $ 267.35M | $ 266.48M | $ 307.39M | $ 296.83M | $ 297.95M |
| Stockholders Equity | $ -185.77M | $ -157.96M | $ 58.96M | $ 67.87M | $ 76.96M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -20.18M | $ -3.06M | $ 7.39M | $ -11.56M | $ -7.02M |
| Operating Cash Flow | $ -20.18M | $ -3.02M | $ 7.61M | $ -11.56M | $ -7.02M |
| Investing Cash Flow | - | $ -44.00K | $ -220.00K | - | - |
| Financing Cash Flow | - | - | - | - | - |
Acorda Therapeutics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.